SEATTLE, WA How do I update this listing?

Omeros Corp is based out of Seattle. Omeros Corporation, a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing products on inflammation and disorders of the central nervous system. Its product candidates are derived from its proprietary PharmacoSurgery platform, which is designed to improve the clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological, and other surgical and medical procedures. The company's lead PharmacoSurgery product candidate, OMS103HP, is in two Phase 3 clinical programs to improve postoperative joint function and reduce pain following arthroscopic anterior cruciate ligament reconstruction surgery, and to reduce pain and improve postoperative joint function following arthroscopic meniscectomy surgery. Its product candidates also include OMS302 for use during ophthalmological procedures, including cataract and other lens replacement surgery; and OMS201 for use during urological surgery, including uroendoscopic procedures of the bladder, ureter, urethra, and other urinary tract structures. The company's pre-clinical developmental programs comprise MASP-2 program, in which it is developing antibody therapies to treat disorders caused by complement activated inflammation; cartilage protective program to treat cartilage disorders, such as osteoarthritis and rheumatoid arthritis; and Phosphodiesterase 10 program for the treatment of schizophrenia; GPCR program to treat a series of CNS disorders. Omeros Corporation was founded in 1994 and is based in Seattle, Washington.Whalewisdom has at least 109 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2010-10-27. The notice included securities offered of Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Create Alert

Contact Info

omeros corp
SEATTLE WA    98119

Business Phone: 206-676-5000

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year


Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2010-10-27 D BIOTECHNOLOGY Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 11,999,970 0 11,999,970
2010-08-13 D BIOTECHNOLOGY Equity 40,000,000 0 40,000,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
DANIEL K SPIEGELMAN subscription required
GREGORY A DEMOPULOS subscription required
JEAN-PHILIPPE TRIPET subscription required
LEROY E. HOOD subscription required
MARCIA S. KELBON subscription required
PETER A DEMOPULOS subscription required
RAY ASPIRI subscription required
THOMAS J CABLE subscription required

Elevate your investments